27535101|t|Intestinal transport of HDND-7, a novel hesperetin derivative, in in vitro MDCK cell and in situ single-pass intestinal perfusion models
27535101|a|1. Hesperetin (HDND) possesses extensive bioactivities, however, its poor solubility and low bioavailability limit its application. HDND-7, a derivative of HDND, has better solubility and high bioavailability. In this study, we investigated the intestinal absorption mechanisms of HDND-7. 2. MDCK cells were used to examine the transport mechanisms of HDND-7 in vitro, and a rat in situ intestinal perfusion model was used to characterize the absorption of HDND-7. The concentration of HDND-7 was determined by HPLC. 3. In MDCK cells, HDND-7 was effectively absorbed in a concentration - dependent manner in both directions. Moreover, HDND-7 showed pH - dependent and TEER - independent transport in both directions. The transport of HDND-7 was significantly reduced at 4 Â°C or in the presence of NaN3. Furthermore, the efflux of HDND-7 was apparently reduced in the presence of MRP2 inhibitors MK-571 or probenecid. However, P-gp inhibitor verapamil had no effect on the transport of HDND-7. The in situ intestinal perfusion study indicated HDND-7 was well-absorbed in four intestinal segments. Furthermore, MRP2 inhibitors may slightly increase the absorption of HDND-7 in jejunum. 4. In summary, all results indicated that HDND-7 might be absorbed mainly by passive diffusion via transcellular pathway, MRP2 but P-gp may participate in the efflux of HDND-7.
27535101	0	10	Intestinal	T023	C0021853
27535101	11	20	transport	T043	C0005528
27535101	24	30	HDND-7	T109,T121,T127	C0019392
27535101	34	39	novel	T080	C0205314
27535101	40	50	hesperetin	T109,T121,T127	C0019392
27535101	51	61	derivative	T169	C1527240
27535101	66	74	in vitro	T080	C1533691
27535101	75	84	MDCK cell	T025	C0598829
27535101	89	129	in situ single-pass intestinal perfusion	T061	C0031006
27535101	130	136	models	T170	C3161035
27535101	140	150	Hesperetin	T109,T121,T127	C0019392
27535101	152	156	HDND	T109,T121,T127	C0019392
27535101	168	177	extensive	T080	C0205231
27535101	206	210	poor	T080	C0542537
27535101	211	221	solubility	T080	C0037628
27535101	226	229	low	T080	C0205251
27535101	230	245	bioavailability	T081	C0005508
27535101	269	275	HDND-7	T109,T121,T127	C0019392
27535101	279	289	derivative	T169	C1527240
27535101	293	297	HDND	T109,T121,T127	C0019392
27535101	310	320	solubility	T080	C0037628
27535101	330	345	bioavailability	T081	C0005508
27535101	382	403	intestinal absorption	T042	C0021826
27535101	418	424	HDND-7	T109,T121,T127	C0019392
27535101	429	439	MDCK cells	T025	C0598829
27535101	465	485	transport mechanisms	T043	C0005528
27535101	489	495	HDND-7	T109,T121,T127	C0019392
27535101	496	504	in vitro	T080	C1533691
27535101	512	515	rat	T015	C0034693
27535101	516	544	in situ intestinal perfusion	T061	C0031006
27535101	580	590	absorption	T067	C2347023
27535101	594	600	HDND-7	T109,T121,T127	C0019392
27535101	606	619	concentration	T081	C1446561
27535101	623	629	HDND-7	T109,T121,T127	C0019392
27535101	648	652	HPLC	T059	C0008562
27535101	660	670	MDCK cells	T025	C0598829
27535101	672	678	HDND-7	T109,T121,T127	C0019392
27535101	683	694	effectively	T080	C1704419
27535101	709	722	concentration	T081	C1446561
27535101	725	734	dependent	T080	C0851827
27535101	750	760	directions	T082	C0439755
27535101	772	778	HDND-7	T109,T121,T127	C0019392
27535101	786	788	pH	T081	C0020283
27535101	791	800	dependent	T080	C0851827
27535101	805	809	TEER	T070	C0162535
27535101	812	823	independent	T033	C1299583
27535101	824	833	transport	T043	C0005528
27535101	842	852	directions	T082	C0439755
27535101	858	867	transport	T043	C0005528
27535101	871	877	HDND-7	T109,T121,T127	C0019392
27535101	896	903	reduced	T080	C0392756
27535101	922	930	presence	T033	C0150312
27535101	934	938	NaN3	T130,T131,T197	C0074721
27535101	957	963	efflux	T044	C1512072
27535101	967	973	HDND-7	T109,T121,T127	C0019392
27535101	989	996	reduced	T080	C0392756
27535101	1004	1012	presence	T033	C0150312
27535101	1016	1020	MRP2	T116,T123	C0525410
27535101	1021	1031	inhibitors	T080	C1999216
27535101	1032	1038	MK-571	T109,T121	C0128634
27535101	1042	1052	probenecid	T109,T121	C0033209
27535101	1063	1077	P-gp inhibitor	T120	C3898062
27535101	1078	1087	verapamil	T109,T121	C0042523
27535101	1092	1101	no effect	T080	C1301751
27535101	1109	1118	transport	T043	C0005528
27535101	1122	1128	HDND-7	T109,T121,T127	C0019392
27535101	1134	1162	in situ intestinal perfusion	T061	C0031006
27535101	1179	1185	HDND-7	T109,T121,T127	C0019392
27535101	1212	1222	intestinal	T023	C0021853
27535101	1223	1231	segments	T082	C1254362
27535101	1246	1250	MRP2	T116,T123	C0525410
27535101	1251	1261	inhibitors	T080	C1999216
27535101	1275	1283	increase	T169	C0442805
27535101	1288	1298	absorption	T067	C2347023
27535101	1302	1308	HDND-7	T109,T121,T127	C0019392
27535101	1312	1319	jejunum	T023	C0022378
27535101	1363	1369	HDND-7	T109,T121,T127	C0019392
27535101	1398	1405	passive	T080	C3686820
27535101	1406	1415	diffusion	T070	C0012222
27535101	1420	1441	transcellular pathway	T043	C2936269
27535101	1443	1447	MRP2	T116,T123	C0525410
27535101	1452	1456	P-gp	T116,T123	C0069906
27535101	1480	1486	efflux	T044	C1512072
27535101	1490	1496	HDND-7	T109,T121,T127	C0019392